Vitamin D3 Receptor (VDR) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  García Martín, Elena ^a   Agúndez, José A G ^a   Martínez, Carmen ^a   Benito León, Julián ^b,c,d   Millán Pascual, Jorge ^e   Calleja, Patricia ^c,d   Díaz Sánchez, María ^c,d   Pisa, Diana ^f   Turpín Fenoll, Laura ^e   Alonso Navarro, Hortensia ^e,g,h   Ayuso Peralta, Lucía ^g   Torrecillas, Dolores ^g   Plaza Nieto, José Francisco ^h   Jiménez Jiménez, Félix Javier ^g,h  

^a UNIVERSITY OF EXTREMADURA   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^e HOSPITAL GENERAL LA MANCHA CENTRO   (Spain)

^f UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^g UNIVERSITY OF ALCALÁ   (Spain)

^h Hospital Universitario del Sureste de Madrid   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL RECEPTOR; HLA DRB1 ANTIGEN;

ADULT; ARTICLE; CAUCASIAN; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HLADRB1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; ONSET AGE; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; VITAMIN D3 RECEPTOR GENE;

ADULT; CASE-CONTROL STUDIES; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; EPISTASIS, GENETIC; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CALCITRIOL; RISK;

EID: 84879260596     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065487     Document Type: Article

References (30)

1. Giordano M, D'Alfonso S, Momigliano-Richiardi P, (2002) Genetics of multiple sclerosis: linkage and association studies. Am J Pharmacogenomics 2: 37-58.
2. Dyment DA, Ebers GC, Sadovnick AD, (2004) Genetics of multiple sclerosis. Lancet Neurol 3: 104-110.
3. Ramagopalan SV, Deluca GC, Degenhardt A, Ebers GC, (2008) The genetics of clinical outcome in multiple sclerosis. J Neuroimmunol 201-202: 183-199.
4. Pugliatti M, Harbo HF, Holmøy T, Kampman MT, Myhr KM, et al. (2008) Environmental risk factors in multiple sclerosis. Acta Neurol Scand Suppl 188: 34-40.
5. Duque B, Sepulcre J, Bejarano B, Samaranch L, Pastor P, et al. (2008) Memory decline evolves independently of disease activity in MS. Mult Scler 14: 947-953.
6. Baranzini SE, (2011) Revealing the genetic basis of multiple sclerosis: are we there yet? Curr Opin Genet Develop 21: 317-324.
7. Kemppinen A, Sawcer S, Compston A, (2011) Genome-wide association studies in multiple sclerosis: lessons and future prospects. Brief Funct Genom 10: 61-70.
8. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, et al. (2011) International Multiple Sclerosis Genetics Consortium; Wellcome Trust Case Control Consortium 2, Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219.
9. Patsopoulos NA, Bayer Pharma MS Genetics Working Group, Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist, ANZgene Consortium, GeneMSA, International Multiple Sclerosis Genetics Consortium (2011) Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol 70: 897-912.
10. Gourraud PA, Harbo HF, Hauser SL, Baranzini SE, (2012) The genetics of multiple sclerosis: an up-to-date review. Immunol Rev 248: 87-103.
11. Simon KC, Munger KL, Ascherio A, (2012) Vitamin D and multiple sclerosis: epidemiology, immunology, and genetics. Curr Opin Neurol 25: 246-251.
12. Handunnetthi L, Ramagopalan SV, Ebers GC, (2010) Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology 74: 1905-1910.
13. Huang J, Xie ZF, (2012) Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case-control studies. J Neurol Sci 313: 79-85.
14. Partridge JM, Weatherby SJ, Woolmore JA, Highland DJ, Fryer AA, et al. (2004) Susceptibility and outcome in MS: associations with polymorphisms in pigmentation-related genes. Neurology 62: 2323-2325.
15. Simon KC, Munger KL, Xing Yang, Ascherio A, (2010) Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler 16: 133-138.
16. Tajouri L, Ovcaric M, Curtain R, Johnson MP, Griffiths LR, et al. (2005) Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet 19: 25-38.
17. Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R, (2009) Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunol 207: 117-121.
18. Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, et al. (2009) Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler 15: 563-570.
19. Cox MB, Ban M, Bowden NA, Baker A, Scott RJ, et al. (2012) Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis. Mult Scler 18: 16-22.
20. Smolders J, Damoiseaux J, Menheere P, Tervaert JW, Hupperts R, (2009) Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Ann N Y Acad Sci 1173: 515-520.
21. Sioka C, Papakonstantinou S, Markoula S, Gkartziou F, Georgiou A, et al. (2011) Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J Negat Results Biomed 10: 3.
22. Agliardi C, Guerini FR, Saresella M, Caputo D, Leone MA, et al. (2011) Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Brain Behav Immun 25: 1460-1467.
23. Irizar H, Muñoz-Culla M, Zuriarrain O, Goyenechea E, Castillo-Triviño T, et al. (2012) HLA-DRB1*15:01 and multiple sclerosis: a female association? Mult Scler 18: 569-577.
24. Orton SM, Ramagopalan SV, Para AE, Lincoln MR, Handunnetthi L, et al. (2011) Vitamin D metabolic pathway genes and risk of multiple sclerosis in Canadians. J Neurol Sci 305: 116-120.
25. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
26. Pértegas Díaz S, Pita Fernández S, (2003) Cálculo del poder estadístico de un estudio. Cad Atención Primaria 10: 59-63.
27. Agúndez JA, Golka K, Martínez C, Selinski S, Blaszkewicz M, et al. (2008) Unraveling ambiguous NAT2 genotyping data. Clin Chem 54: 1390-1394.
28. Zamora J, Abraira V, Muriel A, Khan KS, Coomarasamy A, (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6: 31.
29. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies. J Natl Cancer Inst 22: 719-748.
30. DerSimonian R, Laird N, (1986) Meta-analysis in Clinical Trials. Control Clin Trials 7: 177-188.